Clinical trial
Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis
NCT05247710 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis
- Lead sponsor
- Tampere University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 9, 2022
- Completion date
- June 30, 2024
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.